Research Activities

Learn about research studies that may be of interest to you.

Clinical Trials

Intravenous QAX576 Treatment for Eosinophilic Esophagitis

The Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center is currently conducting a double-blinded, randomized, placebo-controlled clinical trial of intravenous QAX576, a monoclonal antibody to interleukin-13 (IL-13), in the treatment of Eosinophilic Esophagitis (EE). The purpose of this study is to test the safety and efficacy of intravenous QAX576 in patients aged 18 – 50 with EE.  For more information, visit http://www.cincinnatichildrens.org/svc/alpha/e/eosinophilic/research/studies/qax576-treatment.htm.

Eosinophilic Esophagitis (EoE) in Twins and Multiples

The Cincinnati Center for Eosinophilic Disorders (CCED) is studying the occurrence of Eosinophilic Esophagitis (EoE) in twins and multiples. More information about they study and how to participate can be found on their website at http://www.cincinnatichildrens.org/svc/alpha/e/eosinophilic/research/default.htm.

Safety of Investigational Study Product

Mount Sinai Medical Center in New York City is currently recruiting adults who are allergic to peanuts for a clinical research trial looking into the safety of an investigational study product. The study, led by Dr. Scott Sicherer, would involve 13 vaccine dose administrations over a 6-month period. Potential participants must be between 18 and 40 years old and live in New York City or the tri-state area. For more information, please contact clinical coordinator Lisa at (212) 241-7566 or lisa.talarico@mssm.edu. GCO # 04-1271 (0700) IRB approved through June 2010.

For a complete list of clinical trials and answers to commonly asked questions about clinical trials, go to clinicaltrials.gov.

Consortium of Food Allergy Research

The Consortium of Food Allergy Research (CoFAR), funded by the National Institutes of Health, was established to conduct multicenter clinical trials and basic research to find the best possible treatment approaches for food allergy. CoFAR’s lead clinical center is Mount Sinai Medical Center in New York. The other CoFAR institutions are located in Little Rock, Arkansas; Denver, Colorado; Baltimore, Maryland; and Durham, North Carolina. Below is a treatment study for peanut allergy that is currently seeking participants.

Peanut Sublingual Immunotherapy

The aim of this study is to develop a treatment for peanut allergy that may allow patients to become less allergic to peanuts and eventually be able to tolerate peanut protein. Participants must be between 12 and 40 years old. To find out more about this study, go to the study description on clinicaltrials.gov. 

Therapeutic Effect of Chinese Herbal Medicine on Food Allergy (FAHF-2)

Researchers are recruiting patients for a study of a Chinese herbal formula that may reduce or eliminate the risks associated with a life-threatening food allergy. They are enrolling patients between the ages of 12 and 45 who are allergic to peanut, tree nuts, fish, or shellfish. To find out more about this study, go to the study description on clinicaltrials.gov.

An Interventional Study of Milk Allergy and Tolerance in Children

The aim of this study is to determine if children who are allergic to milk can increase their tolerance to milk. Participants must be between 4 and 10 years of age. To find out more about this study, go to the study description on clinicaltrials.gov.

Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis

The aim of this study is to evaluate the safety of Oral Viscous Budesonide (OVB). Participants must be between the ages of 2 and 18 and have a history of eosinophilic esophagitis. For more information about this study, go to clinicaltrials.gov.

Disclaimer and Limitation of Liability

The Food Allergy & Anaphylaxis Network serves only as a point of contact for the research projects listed on this web page. The Food Allergy & Anaphylaxis Network does not endorse and is not affiliated in any other way with these research projects, unless otherwise noted. The Food Allergy & Anaphylaxis Network makes no promises or warranties, expressed and implied, as to the appropriateness of any given research project listed on this Web site. The Food Allergy & Anaphylaxis Network disclaims all warranties of fitness for a particular purpose and merchantability as to all such matters. The Food Allergy & Anaphylaxis Network will not be liable under any circumstances for any damages arising from participation in any of the research projects listed on this Web site, whether such losses are special, incidental, consequential, or otherwise.

E-Mail Print Bookmark and Share